Diabetes drug link to prostate cancer

The Food and Drug Administration are probing new data that indicates drugs used to treat prostate cancer could increase the risk of diabetes and heart disease . The drugs, which are used to suppress testosterone, may fuel the growth of prostate cancer tumours . The drugs are also sometimes used to treat women suffering from a specific uterine complaint.
The FDA have gone on record saying that the drugs are not conclusively linked to health problems. However, six preliminary studies show slightly higher rates of diabetes and heart disease .
Doctors are being advised to closely monitor diabetes patients for any sign of either diabetes or heart disease. Specific diabetes drugs under scrutiny include Zoladex, Synarel, and Lupron.